Company Presentation • 22 Oct 2025 21:00
Company Presentation • 27 Aug 2025 16:00
Company Presentation • 25 Jun 2024 20:30
Company Presentation • 28 Jun 2025 08:00
Company Presentation • 26 Mar 2025 16:00
Search or
𝛼SK
𝛼SKENTITY
Innovent Biologics Inc (1801 HK)
Innovent Biologics Inc (1801 HK)
516
Analysis
Health Care • China
Innovent Biologics, Inc. operates as a biopharmaceutical company. The Company develops, manufactures, and distributes monoclonal antibody drug candidates for the treatment of oncology, ophthalmology, autoimmune, cardiovascular, and other diseases. Innovent Biologics serves customers in China.
morex